CAM
PFE icon

Cidel Asset Management’s Pfizer PFE Stock Holding History

Cidel Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.36M Buy
97,941
+3,700
+4% +$96.8K 0.11% 110
2026
Q1 		$2.65M Buy
94,241
+16,288
+21% +$434K 0.14% 91
2025
Q4 		$1.94M Sell
77,953
-814
-1% -$20.5K 0.14% 93
2025
Q3 		$2.01M Buy
78,767
+1,990
+3% +$49.1K 0.12% 88
2025
Q2 		$1.86M Buy
76,777
+2,373
+3% +$55.3K 0.11% 93
2025
Q1 		$1.89M Sell
74,404
-576
-0.8% -$15.1K 0.12% 87
2024
Q4 		$1.99M Buy
74,980
+9,029
+14% +$245K 0.13% 81
2024
Q3 		$1.91M Buy
65,951
+6,958
+12% +$203K 0.13% 84
2024
Q2 		$1.65M Buy
58,993
+7,261
+14% +$200K 0.13% 82
2024
Q1 		$1.44M Buy
51,732
+6,573
+15% +$182K 0.11% 88
2023
Q4 		$1.3M Buy
+45,159
New +$1.37M 0.06% 101
2022
Q3 		– Sell
-6,965
Closed -$365K – 142
2022
Q2 		$365K Hold
6,965
– – 0.02% 119
2022
Q1 		$361K Sell
6,965
-1,179
-14% -$61.2K 0.01% 125
2021
Q4 		$481K Hold
8,144
– – 0.02% 110
2021
Q3 		$350K Sell
8,144
-201
-2% -$8.9K 0.01% 114
2021
Q2 		$327K Sell
8,345
-1,513
-15% -$58.8K 0.01% 122
2021
Q1 		$357K Sell
9,858
-1,830
-16% -$65K 0.02% 106
2020
Q4 		$430K Buy
11,688
+2,593
+29% +$95.1K 0.02% 88
2020
Q3 		$317K Hold
9,095
– – 0.02% 96
2020
Q2 		$282K Buy
9,095
+2,140
+31% +$72.7K 0.01% 98
2020
Q1 		$215K Sell
6,955
-1,605
-19% -$54.7K 0.01% 98
2019
Q4 		$318K Sell
8,560
-40,947
-83% -$1.46M 0.01% 92
2019
Q3 		$1.69M Buy
+49,507
New +$1.8M 0.08% 65
2019
Q2 		– Sell
-9,726
Closed -$392K – 131
2019
Q1 		$392K Sell
9,726
-791
-8% -$31.7K 0.02% 97
2018
Q4 		$436K Buy
10,517
+580
+6% +$24.1K 0.03% 72
2018
Q3 		$415K Hold
9,937
– – 0.02% 74
2018
Q2 		$342K Buy
+9,937
New +$340K 0.02% 80

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cidel Asset Management's PFE Position: Q2 2026 in Review

Cidel Asset Management increased its Pfizer (PFE) stake by 3.9% in Q2 2026, buying an estimated $96.8K and bringing the position to 97,941 shares worth $2.36M. The position accounts for 0.11% of the portfolio, ranked #110.

Cidel Asset Management first reported a position in PFE in Q2 2018 and has held it in 27 quarters since. The position peaked at $2.65M in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Cidel Asset Management held 97,941 shares of Pfizer worth $2.36M as of Q2 2026.
  • Cidel Asset Management bought 3,700 Pfizer shares in Q2 2026, an estimated $96.8K.
  • Pfizer made up 0.11% of Cidel Asset Management's portfolio in Q2 2026, its #110 holding.
  • Cidel Asset Management first reported a position in Pfizer in Q2 2018 and has held it in 27 quarters since.
  • Cidel Asset Management's Pfizer position peaked at $2.65M in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cidel Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.